Last update:

Alzheimer's disease & dementia news

Neuroscience

40Hz sensory stimulation may benefit some Alzheimer's patients for years, small study suggests

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for around two years after participating in an MIT early-stage clinical study of the potential Alzheimer's ...

Alzheimer's disease & dementia

Role of brain inflammation in Alzheimer's and Parkinson's may depend on the behavior of microglia

Researchers from the Alzheimer's Center at Temple (ACT) provide new insights into how microglia, the brain's immune cells, exhibit an apparent dual function with the ability to both increase and decrease inflammation in the ...

Neuroscience

Scientists find ways to boost memory in aging brains

Memory loss may not simply be a symptom of getting older. New research from Virginia Tech shows that it's tied to specific molecular changes in the brain and that adjusting those processes can improve memory.

Alzheimer's disease & dementia

Stiff arteries may amplify early memory decline in older adults

Findings from the multisite IGNITE clinical trial suggest that arterial stiffness, which occurs when large blood vessels lose their natural flexibility, may be linked to greater injury effects to brain nerve fibers in older ...

Psychology & Psychiatry

Helpline support eases stress for dementia caregivers

Family caregivers for people with dementia report emotional strain from witnessing personality changes, physical exhaustion from providing intensive supervision, social isolation, and financial hardship. To receive counseling ...

Alzheimer's disease & dementia

New brain imaging technique can detect early frontotemporal dementia

A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle changes in the brain and identify early signs of hereditary frontotemporal dementia using advanced brain ...

Medications

European watchdog partially approves new Alzheimer's drug

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.

Neuroscience

Indicators of an aging brain: A 20-year study

Johns Hopkins University-led researchers, working with the Biomarkers for Older Controls at Risk for Dementia (BIOCARD) cohort, have found that certain factors are linked to faster brain shrinkage and quicker progression ...

Alzheimer's disease & dementia

New criteria to avoid the over-diagnosis of Alzheimer's disease

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted. To counter this problem, a global expert panel ...